🇺🇸 FDA
Patent

US 9169297

Subgenomic replicons of the flavivirus dengue

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 9169297 (Subgenomic replicons of the flavivirus dengue) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/5258, A61K2039/53